Notably, there is a precedent for SULF modulation of EGFR signaling in that SULF2 knockdown in astrocytoma cells led to a reduction in EGFR activation, as well as that of several other receptor tyrosine kinases [25]. This evidence concerns the gene NTRK1 and astrocytoma (excluding glioblastoma).